Cargando…
Food and drug administration’s critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies
During the last decade, despite increased investment in drug research and development related activity, stagnation in new drug discovery has been documented. Despite a 70% increase in investment in research and development-related activities, a 40% fall in launch of new chemical entities was seen du...
Autores principales: | Mahajan, Rajiv, Gupta, Kapil |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996064/ https://www.ncbi.nlm.nih.gov/pubmed/21180462 http://dx.doi.org/10.4103/0975-7406.72130 |
Ejemplares similares
-
Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019) -
Blood test to help diagnose type 1 diabetes approved by Food and Drug Administration
por: Mahajan, Rajiv
Publicado: (2015) -
Distinguishing Viral and Bacterial Infections Made Easy Through the Food and Drug Administration Approved Technology-Assisted Diagnosis
por: Mahajan, Rajiv
Publicado: (2021) -
Adaptive design clinical trials: Methodology, challenges and prospect
por: Mahajan, Rajiv, et al.
Publicado: (2010) -
Challenges and Controversies in Defining Totally Drug-Resistant Tuberculosis
por: Cegielski, Peter, et al.
Publicado: (2012)